
|Articles|April 14, 2020
Life Sciences and Information Technology Companies Join EndPandemic National Data Consortium to Integrate COVID-19 Clinical Data
Advertisement
The EndPandemic National Data Consortium has announced that it has received commitments from six life sciences and information technology companies to join the Consortium. The companies will work together toward the goal of integrating data from all ongoing and future clinical studies to accelerate analysis on COVID-19 and SARS-CoV-2 research in order to reduce the time to find a cure by up to 50%.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5




